News Center
With the tenet of "Healthy China, Dedicated commitment", Linuo Pharmaceuticals increases cooperation and association with external scientific research institutes while innovating and developing independently.
11
2024
-
05
Brand Empowerment Times Strong Voice | Lino Pharmaceutical Glory Awarded Xinhua News Agency "Typical Case of Brand Credit Construction in Big Health Field"!
Classification：
News
行业新闻
Corporate News
Brand, make the world better. May 10,Xinhua News Agency, China Brand Building Promotion AssociationSuch as joint guidance, sponsored2024 World Brand Moganshan ConferenceGrand opening in Deqing County, Huzhou City, Zhejiang Province.
China Digital Intelligence Pharmaceutical Innovation Brand-LiNuo PharmaceuticalInvited to attend the meeting, together with the brand big coffee, analysisWorld brand development pattern, issued a strong voice of the times of Chinese brands.
The theme of this conference is "brand, make the world a better place"Around the worldRepresentatives of well-known enterprises and local governments, overseas media, global academic institutions and industry associations 4More than 000 people gathered together., focusing on global brand topics, gathering global brand views, making global brand voices, and the collision of ideas is brilliant.Famous in the field of brand building at home and abroadOne of the activities.
The conference site released"BigTypical Cases of Brand Credit Construction in Health Field"The results of the selection, the list of enterprises in the product.Brand influence, brand innovation practice results, credit managementAnd other aspects have a higher contribution. Lino Pharmaceuticals by virtueThe good reputation accumulated in the field of chronic diseases for more than 20 years., and innovative exploration in the field of digital medicine in recent years.Glory on the list.
Deep ploughing in the field of chronic diseases for more than 20 years
Heart to fulfill the promise
Founded in 2002, lino pharmaceutical is the leading enterprise in China's chemical raw material drug subdivision track.Keyuan Pharmaceutical (Stock Code: 301281.SZ) wholly-owned subsidiary, with the mission of "using digital medicine to protect life and health", focusing on the preparation business.
For more than 20 years, the company has beenCardiovascular, central nervous system, hypoglycemic, respiratory systemWe have established a rich product line in the field of diseases and accumulated strong research and development strength. By virtueIntegration of raw materials and excipientsThe company's high-quality drugs continue to benefit patients across the country.Sustainable Contribution to the Construction of Healthy China.
InCredit Management Aspects, the company attaches great importance to integrity management, always adhere to the principle of compliance management, strictly abide by the relevant laws and regulations and industry norms;Brand building aspectThe company continuously improves brand influence and market recognition by strengthening brand positioning, improving product quality and service level.
With hard core quality management, cutting-edge technology research and development strength, excellent product reputation,Linuo Pharmaceuticals has been awardedThe Most Growing Enterprise in China's Pharmaceutical Industry,Shandong province "specialized and special new" small and medium-sized enterprises, Jinan enterprise technology centerand other honorary titles.
Digital Intelligence Medicine
Big health industry forerunner
Brand is a symbol of high quality development. The transformation and transformation of Digital Intelligence Pharmaceuticals has enabled Lino Pharmaceuticals to achieve a brand transition.
in the globalProfound changes in the big health industryAt present, the traditional development model of the pharmaceutical industry is facing an impact,The transformation of digital intelligence will become the core driving force for the development of the industry in the future.. In the tide of industry change, Rino Pharmaceuticals has demonstrated its roleThe Ability and Responsibility of the Pioneer of Digital Intelligence Medicine, continue to introduce international advanced management concepts, technology and equipment, cultivate and form new quality productivity, and realize the whole process of digital intelligent management from R & D to production and sales
to improve research and development efficiency and product quality.
The company has startedMultiple Digital Intelligence Manufacturing ProjectsAll projects are in accordanceIntelligent manufacturing four standard planning and constructionWe are committed to building a high-level and internationalDigital Intelligence Pharmaceutical Lighthouse Factory and Pharmaceutical Innovation R & D Highland!
The future, the company's creationNew R & D, Digital Intelligence Manufacturing, Cultural Marketing, Medical Servicesand other business units willRealize data interconnectionJinan base as the computing center, the use of information and digital intelligence platform, innovative leading process layout, international marketing service concept,Strengthen the positioning of China's digital medicine innovation brand, set the industry benchmark.
Evaluated this time.2024 Moganshan World Brand Conference "Typical Cases of Brand Credit Construction in Big Health Field" Award, is to lino pharmaceutical for many years inBrand building and credit managementrecognition and encouragement.
lino pharmaceutical will continue to uphold the"Industry for the country, the pursuit of excellence"The brand spirit, and constantly improveProduct quality and service levelStrengthen brand building, make greater contributions to people's lives and health, and help Chinese brand building achieve high-quality development.
Related news
ADD：#30766 Jingshidong Road, Linuo High-tech Park, Jinan, Shandong Province, P. R. China